Treatment with direct-acting antivirals improves the clinical outcome in patients with HCV-related decompensated cirrhosis: results from an Italian real-life cohort (Liver Network Activity—LINA cohort)Ivan Gentile, Nicola Coppola, Riccardo Scotto et al.|Hepatology International|2018Cited by 63
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in ItalyValentina Burgio, Andrea Casadei‐Gardini, Gianluca Masi et al.|Cancer Management and Research|2021Cited by 38
Interferon-free regimens improve kidney function in patients with chronic hepatitis C infectionIvan Gentile, Federica Portunato, Antonio Riccardo Buonomo et al.|Journal of Nephrology|2019Cited by 30
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrenceAntonio Riccardo Buonomo, Ivan Gentile, Riccardo Scotto et al.|Medicine|2020Cited by 9